Company
EMvision Medical Devices Limited
Headquarters: Macquarie Park, NSW, Australia
CEO: Dr. Ronald Peter Weinberger AIMM, BSc (Hons), Ph.D.
Market Cap
A$152.0 Million
AUD as of Jan. 1, 2024
US$103.5 Million
EMvision Medical Devices Limited Categories
Australia Healthcare Medical DevicesAustralia Healthcare Australia Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
EMvision Medical Devices Limited, a medical device company, engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for point of care, stroke diagnosis, and monitoring. The company was incorporated in 2017 and is based in Macquarie Park, Australia.
Top 1-year algo backtest: +298.72%
$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
EMvision Medical Devices Limited has the following listings and related stock indices.
Stock: ASX: EMV wb_incandescent